Navigation Links
Controversy over Copeman Healthcare fee

Profit based Vancouver Company Copeman Healthcare Inc.’s may face charges of legal action and fine as the company plans to charge an initial consultation fee of $3,500. // The Ontario Health Coalition is going to submit a memorandum to the Health ministry to take action against the Copeman Healthcare as the coalition is against money based treatment and recommends universal rate for all treatment.

Copeman Healthcare is aimed at setting up profit based clinics providing best treatment and consultation to its paid customers at an annual fee of $2,300 which offers better hospital infrastructure, consultation on the same day, specialist consultation and early surgery dates.

Ontario Health Ministry is against the new proposed Healthcare as they feel that the new system will benefit only the rich and treatment based on money. The ministry also warns any individual paying fee to the Copeman would be fined around $10,000 and even doctors accepting the fees would be liable to fine of up to $25,000.


'"/>




Page: 1

Related medicine news :

1. Herbal Drug In Controversy
2. The Existing Controversy of Hormone Replacement Therapy
3. A Settlement Over Stem Cell Controversy Through Scientific Research
4. Controversy over spread of Mad Cow disease from India
5. French Fries In Cancer Controversy In China
6. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
7. Controversy: Malaria Vaccine - Future Possibility Or Just A Dream?
8. The Looming Controversy Surrounding Facial Transplant
9. Controversy over Healthy diet may lead to less red meat in diet
10. The Publication Of Surgeon Specific Death Rates Raises Controversy
11. Controversy over Fees Structure in Private Medical Colleges
Post Your Comments:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Pancreatic cancer risk decreased by one anti diabetic therapy increased by others 53409 1Pancreatic cancer risk decreased by one anti diabetic therapy increased by others 53409 2Race ethnicity family income and education associated with sugar consumption 9451 1Race ethnicity family income and education associated with sugar consumption 9451 2Hispanic Alliance Urges Congress to Work Through Recess on Health 53403 1Hispanic Alliance Urges Congress to Work Through Recess on Health 53403 2